SC 13G/A: TREACE MEDICAL CONCEPTS, INC.
Ticker: TMCI · Form: SC 13G/A · Filed: 2024-11-07T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by TREACE MEDICAL CONCEPTS, INC..
Risk Assessment
Risk Level: low
Filing Stats: 815 words · 3 min read · ~3 pages · Grade level 8.7 · Accepted 2024-11-07 17:00:02
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti
Filing Documents
- jttreacesched13ganov2024.htm (SC 13G/A) — 66KB
- 0000950170-24-123492.txt ( ) — 67KB
(a) Name of Issuer
ITEM 1. (a) Name of Issuer: Treace Medical Concepts, Inc. (the “Issuer”). (b) Address of Issuer’s Principal Executive Offices: 100 Palmetto Park Place, Ponte Vedra, Florida 32081
(a) Name of Person Filing
ITEM 2. (a) Name of Person Filing: This statement is filed on behalf of John T. Treace (the “Reporting Person”). (b) Address or Principal Business Office: The business address of the Reporting Person is c/o Treace Medical Concepts, Inc., 100 Palmetto Park Place, Ponte Vedra, Florida 32081. (c) Citizenship of each Reporting Person is: The Reporting Person is a citizen of the United States. (d) Title of Class of Securities: Common stock, $0.001 par value (“Common Stock”). (e) CUSIP Number: 89455T109 ITEM 3. Not applicable. CUSIP No. 89455T109 Schedule 13G Page 3 of 5
Ownership
ITEM 4. Ownership. (a-c) The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of September 30, 2024, based upon 62,275,371 shares of Common Stock outstanding as of September 30, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2024. Reporting Person Amount beneficially owned Percent of class: Sole power to vote or to direct the vote: Shared power to vote or to direct the vote: Sole power to dispose or to direct the disposition of: Shared power to dispose or to direct the disposition of: John T. Treace 11,828,211 18.9% 8,343,145 3,485,066 8,343,145 3,485,066 John T. Treace may be deemed the beneficial owner of 11,828,211 shares of Common Stock, which includes (i) 6,326,631 shares of Common Stock held of record by the Reporting Person, (ii) 1,839,063 shares of Common Stock held of record by a family trust, of which the Reporting Person is trustee, (iii) 1,605,000 shares of Common Stock held of record by Reporting Person’s spouse, (iv) 1,471,250 shares of Common Stock held of record by a family trust, of which the Reporting Person’s spouse is co-trustee, (v) 408,816 shares of Common Stock held of record by a family trust, of which the Reporting Person is co-trustee and (vi) 177,451 shares of Common Stock underlying stock options that are either currently exercisable or will be exercisable within 60 days of September 30, 2024.
Ownership of Five Percent or Less of a Class
ITEM 5. Ownership of Five Percent or Less of a Class. Not applicable.
Ownership of More than Five Percent on Behalf of Another Person
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.
Identification and Classification of Members of the Group
ITEM 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
ITEM 9. Notice of Dissolution of Group. CUSIP No. 89455T109 Schedule 13G Page 4 of 5 Not applicable.
Certification
ITEM 10. Certification. Not applicable. CUSIP No. 89455T109 Schedule 13G Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : November 7, 2024 John T. Treace /s/ John T. Treace